Pharmacokinetics, pharmacodynamics, safety and tolerability of APG101, a CD95-Fc fusion protein, in healthy volunteers and two glioma patients

Erstveröffentlichung
2012Authors
Tuettenberg, Jochen
Seiz, Marcel
Debatin, Klaus-Michael
Hollburg, Wiebke
von Staden, Michael
Wissenschaftlicher Artikel
Published in
International Immunopharmacology ; 13 (2012), 1. - S. 93-100. - ISSN 1567-5769
Link to publication
https://dx.doi.org/10.1016/j.intimp.2012.03.004Institutions
UKU. Klinik für Kinder- und JugendmedizinSubject headings
[Free subject headings]: APG101 | CD95 | Phase I | Pharmacokinetics | Pharmacodynamics | Glioblastoma | immune-system | apoptosis | receptor | cancer[DDC subject group]: DDC 610 / Medicine & health